IRCT2015012019470N13已完成2 期
Evaluation of the effect of infusion of GIK (glucose-Insulin-potassium ) solution on serum lactate and central VO2 during CABG surgeries
Vice Chancellor for Research, Shiraz University of Medical Sciences0 个研究点目标入组 74 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 74
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 80 years（—）
- 性别
- All
入选标准
- •age 80-30 years, the first heart surgery, coronary artery bypass graft surgery, the patient informed consent for inclusion; EF less than 40%
- •Exclusion criteria: Pregnancy; lack of informed consent; patients undergoing dialysis; 200 mmol / L ? Cr; acute coronary syndrome; 5- 350 < FBS; In the circumstances that infusion of GIK will be stopped: 5.5 mmol / L <K increased cardiac markers such as troponin and CPK
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Effect of administration of GIK (Glucose-Insulin-Potassium) Solution on clinical outcomes after heart surgeryChildren with heart disease.IRCT20190109042306N1Esfahan University of Medical Sciences70
已完成
2 期
Effects of Glucose Insulin Potassium infusion on inflammatory markers in patients with acute heart failureAcute heart failure.Heart failure, unspecifiedIRCT201111238185N1Vice chancellor for research and technology, Kermanshah university of medical sciences50
已完成
不适用
Glucose-insulin-potassium (GIK) treatment in non-diabetic females undergoing cardiac surgery trialCardiac surgerySurgeryISRCTN66835102Department of Health (UK)400
已完成
3 期
Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK AloneAcute Coronary SyndromeNCT00965406University of Monastir772
招募中
不适用
Effect of Glucose-Insulin-Potassium in Creatine Phosphokinase (CPK)IRCT20211220053468N1Shahid Beheshti University of Medical Sciences70